Font Size: a A A
Keyword [malignant gliomas]
Result: 21 - 40 | Page: 2 of 2
21. 1p/19q LOH And Promoter Methylation Of DNA Repair Gene MGMT Guided Treatment For Malignant Gliomas
22. The Analysis On The Long-term Survival Cause Of The Patients With Malignant Glioma
23. Clinical Efficacy Of Intensity Modulated Radiation Therapy Combined With Concomitant And Adjuvant Temozolomide In The Treatment For Malignant Glioma
24. Expression, Purification Of Recombinant Human Interferonβ In Escherichia Coli And Its Induction Of Autophagy In Malignant Gliomas
25. Biodistribution And Imaging Of131I Labeled Anti-Neuropilin-1Monoclonal Antibody In Malignant Gliomas
26. Resection Of Glioma With Fluorescence-sodium Guided: A Clinical Study
27. Dosimetric Study Of RapidArc Radiation Therapy And Five-fields Intensity Modulated Radiation Therapy For Malignant Gliomas
28. MGMT Methylation And EGFR Expression Detection Guided Treatment For Malignant Gliomas
29. Analysis Of Clinical Efficacy Of Malignant Glioma With Personalized Treatment
30. The Study Of The Value Of MRS In The Differential Diagnosis Between Brain Metastases And Malignant Gliomas
31. Clinical Significance And Prognostic Value Of 1p/19q Co-deletion And IDH1 Gene Mutation In Malignant Gliomas
32. Overexpression Of Nek2 In Malignant Gliomas And Its Prognostic Value In Glioblastoma
33. Gene Therapy Using TRAIL-secreting Menstrual Blood Derived Mesenchymal Stem Cells Against Glioma
34. The Relationship Between The Expression Of TGF-β And GFAP In Brain Malignant Gliomas And Prognosis
35. Activity And Safety Of Bevacizumab Plus Temozolomide For Recurrent Malignant Gliomas
36. Analysis Of Postoperative Radiotherapy And Chemotherapy Efficacy And Prognostic Factors For Malignant Gliomas
37. Study On The Correlation Between IDH1 Gene Mutation And MTOR Expression In Human Gliomas Prognosis
38. Correlation Between MGMT Gene Promoter Mathylation And Efficacy Of Temozolomide In Patients With Malignant Gliomas
39. Gene expression profiling of chemoresistance in human malignant gliomas
40. The biological role of the CDKN2A gene in the progression of human malignant gliomas
  <<First  <Prev  Next>  Last>>  Jump to